Healthtech Startups

Modalis Therapeutics develops therapeutics using CRISPR gene-editing technology and provides its platform technology for drug development. It operates in the biotechnology sector.

5 investors

precal is an automated pharmacy reception and prescription data-entry service for pharmacies in Japan, where patients scan prescriptions at a tablet and remote online clerks enter the data. It uses RPA to automatically input prescription data into the pharmacy's dispensing/receipt computer (recekon) and handles printing, reducing pharmacy staff workload.

4 investors

1Life Healthcare operated One Medical, a membership-based primary care organization offering in-person clinics and virtual care across the United States. Acquired by Amazon in 2023.

4 investors

FitXpress uses AI-powered computer vision to estimate body weight from images, enabling verification of self-reported data for BMI calculations in healthcare and wellness applications. The service is designed for healthcare providers and wellness programs requiring accurate biometric validation.

4 investors

4 investors

3T Biosciences develops TCR-based immunotherapies for cancer using a proprietary platform that combines machine-learning algorithms with immunological research to identify and validate T cell receptor targets. The company creates therapeutic treatments targeting cancer and other difficult-to-treat diseases.

4 investors

5C Network operates an AI-native teleradiology platform where AI analyzes CT, MRI, X-ray, and PET-CT scans and radiologists review and sign off on the diagnosis, delivering structured reports in about 30 minutes. It serves hospitals, diagnostic centres, and chains primarily across India, reading over 15,000 radiology studies daily.

4 investors

A2 Bio develops precision CAR T-cell therapies using its Tmod cell engineering platform, supporting both autologous and allogeneic applications. The company targets cancer and other serious diseases, advancing its cell therapies through clinical trials.

4 investors

Aadi Bioscience develops therapies targeting mTOR-driven diseases using precision medicine and albumin-bound nanoparticle technology, applying genomic profiling to identify patients most likely to benefit from mTOR inhibition. It operates in the biotechnology and pharmaceutical sector.

4 investors

Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule drugs that inhibit hunger to treat metabolic diseases. Its lead compound, ARD-101, is an oral investigational drug for hunger-associated rare diseases that activates bitter taste receptors in the gut to trigger satiety signals, with potential applications in hyperphagia and obesity.

4 investors

Able Health provides software for physician organizations to administer value-based care programs, including quality measure calculation and health plan coordination to reduce administrative overhead.

4 investors

Abstractive Health provides AI-powered medical record summarization and pre-visit review tools for clinicians. The platform consolidates fragmented patient records and clinical data to help healthcare providers prepare for appointments with summarized patient insights.

4 investors

A primary care and obesity/metabolic health clinic offering virtual and in-person visits with integrated nutrition counseling, health coaching, and remote patient monitoring to help patients achieve personalized wellness goals.

4 investors

AceCann cultivates, processes, and extracts medical cannabis products aimed at the European market. The company produces its products to pharmaceutical standards for use in the medical cannabis sector.

4 investors

Acrivon is a clinical-stage oncology company developing precision medicine therapeutics for cancer treatment, using its proprietary AP3 proteomics platform to create companion diagnostics that match patients to drugs based on tumor-driving mechanisms.

4 investors

Actithera develops a chemistry platform for targeted cancer treatment that optimizes radiation dose absorption in tumors while reducing exposure to healthy tissue, with flexibility to pair different radionuclides based on tumor characteristics.

4 investors

ADC Therapeutics is a biopharmaceutical company that develops antibody drug conjugates and other therapies focused on hematology and oncology. It operates in the biotech and pharmaceutical industry.

4 investors

Adicet Bio develops allogeneic gamma delta CAR T cell therapies for patients with autoimmune diseases and cancer. The company works on off-the-shelf immune cell therapies based on gamma delta 1 CAR T cell technology.

4 investors

Adipo develops investigational therapeutics that promote weight loss by activating brown fat to increase energy expenditure, offering an alternative to appetite-suppressing drugs like GLP-1s. The company targets people seeking weight management solutions beyond diet and calorie restriction.

4 investors

Adni operates a platform connecting healthcare workers with employment opportunities while providing tools for credential management and professional networking; the platform also serves healthcare employers seeking to identify and screen clinical talent through AI-powered recruiting capabilities.

4 investors

Aer Therapeutics develops a science-driven therapeutic aimed at eliminating mucus plugs in the lungs to treat muco-obstructive lung diseases such as COPD and asthma. The company focuses on respiratory care for patients with these conditions.

4 investors

Aerin Medical develops non-invasive radiofrequency treatment systems for chronic nasal conditions, offering the VivAer stylus for nasal airway obstruction and RhinAer stylus for chronic rhinitis. The treatments are performed in doctor's offices and operating rooms using a touch-screen console that delivers temperature-controlled radiofrequency therapy.

4 investors

Affini-T Therapeutics develops TCR-based immunotherapies aimed at treating solid tumors, using two complementary therapeutic modalities. The company operates in the biotech and cancer immunotherapy space.

4 investors

Afilio provides digital estate planning and family care documentation services for German-speaking users. The platform enables families to organize advance directives, inheritance information, and emergency contacts in one secure, legally compliant location.

4 investors